Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 10, 2005, Pages 1182-1191

  Simell, Satu ^a   Kupila, Antti ^a   Hoppu, Sanna ^a,b   Hekkala, Anne ^a,c   Simell, Tuula ^a   Ståhlberg, Marja Riitta ^a   Viander, Markku ^a   Hurme, Timo ^a   Knip, Mikael ^a,d   Ilonen, Jorma ^a   Hyöty, Heikki ^a,e   Simell, Olli ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Birth cohort; Celiac disease; Children; Screening; Transglutaminase autoantibodies

Indexed keywords

AUTOANTIBODY; GLUTEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ABDOMEN; ANTIBODY DETECTION; ARTICLE; ATROPHY; BLOOD ANALYSIS; BLOOD SAMPLING; CELIAC DISEASE; CHILD; DIET; DIET THERAPY; DISEASE PREDISPOSITION; DUODENUM BIOPSY; FOLLOW UP; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; INTESTINE MUCOSA; INTESTINE VILLUS; MAJOR CLINICAL STUDY; PARENTAL CONSENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROCONVERSION;

AUTOANTIBODIES; BIOLOGICAL MARKERS; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DUODENUM; FEMALE; FINLAND; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLIADIN; HAPLOTYPES; HLA ANTIGENS; HUMANS; IGA DEFICIENCY; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; INTESTINAL MUCOSA; MALE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSGLUTAMINASES;

EID: 27144456804     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520510024034     Document Type: Article

References (29)

1. Visakorpi JK, Mäki M. Changing clinical features of coeliac disease. Acta Paediatr 1994;Suppl 83:10-3.
2. Hansson T, Dahlbom I, Rogberg S, Dannaeus A, Hopfl P, Gut H, et al. Recombinant human tissue transglutaminase for diagnosis and follow-up of childhood coeliac disease. Pediatr Res 2002;51:700-5.
3. Mäki M, Kallonen K, Lähdeaho ML, Visakorpi JK. Changing pattern of childhood coeliac disease in Finland. Acta Paediatr Scand 1988;77:408-12.
4. Kolho KL, Färkkila MA, Savilahti E. Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol 1998;33:1280-3.
5. Collin P, Reunala T, Rasmussen M, Kyrönpalo S, Pehkonen E, Laippala P, et al. High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol 1997;32:1129-33.
6. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286-92.
7. Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517-24.
8. Polvi A, Arranz E, Fernandez-Arquero M, Collin P, Mäki M, Sanz A, et al. HLA-DQ2-negative celiac disease in Finland and Spain. Hum Immunol 1998;59:169-75.
9. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis (published erratum appears in Gastroenterology 1994;106:1133). Gastroenterology 105;1993:910-22.
10. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease [see comments]. Nat Med 1997;3:797-801.
11. Bürgin-Wolff A, Dahlbom I, Hadziselimovic F, Petersson CJ. Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterol 2002;537:685-91.
12. Ivarsson A, Hernell O, Stenlund H, Persson LA. Breast-feeding protects against celiac disease. Am J Clin Nutr 2002;75:914-21.
13. Peters U, Schneeweiss S, Trautwein EA, Erbersdobler HF. A case-control study of the effect of infant feeding on celiac disease. Ann Nutr Metab 2001;45:135-42.
14. Ascher H, Holm K, Kristiansson B, Mäki M. Different features of coeliac disease in two neighbouring countries. Arch Dis Child 1993;69:375-80.
15. Trevisiol C, Ventura A, Baldas V, Tommasini A, Santon D, Martelossi S, et al. A reliable screening procedure for coeliac disease in clinical practice. Scand J Gastroenterol 2002;37:679-84.
16. Johnston SD, Watson RG, McMillan SA, Evans AE, Love AH. Serological markers for coeliac disease: changes with time and relationship to enteropathy. Eur J Gastroenterol Hepatol 1998;10:259-64.
17. Agardh D, Carlsson A, Lynch K, Axelsson I, Lemmark A, Ivarsson SA. Using radioligand-binding assays to measure tissue transglutaminase autoantibodies in young children. Acta Paediatr 2004;93:1046-51.
18. Hoffenberg EJ, MacKenzie T, Barriga KJ, Eisenbarth GS, Bao F, Haas JE, et al. A prospective study of the incidence of childhood celiac disease. J Pediatr 2003;143:308-14.
19. Barera G, Bonfanti R, Viscardi M, Bazzigaluppi E, Calori G, Meschi F, et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2002;109:833-8.
20. Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Ivarsson SA. Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 2001;107:42-5.
21. Kupila A, Keskinen P, Simell T, Erkkilä S, Arvilommi P, Korhonen S, et al. Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes 2002;51:646-51.
22. Nejentsev S, Sjöroos M, Soukka T, Knip M, Simell O, Lövgren T, et al. Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 1999;16:985-92.
23. Savilahti E, Viander M, Perkkiö M, Vainio E, Kalimo K, Reunala T. IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease. Lancet 1983;1:320-2.
24. Oberhuber G. Histopathology of celiac disease. Biomed Pharm 2000;54:368-72.
25. Kaukinen K, Mäki M, Partanen J, Sievänen H, Collin P. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci 2001;46:879-87.
26. Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Lindberg BA, Sjöberg KG, et al. Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Pediatrics 1999;103:1248-52.
27. Bonamico M, Mariani P, Thanasi E, Ferri M, Nenna R, Tiberti C, et al. Patchy villous atrophy of the duodenum in childhood celiac disease. J Pediatr Gastroenterol Nutr 2004;38:204-7.
28. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999;117:297-303.
29. Hahl J, Simell T, Ilonen J, Knip M, Simell O. Costs of predicting IDDM. Diabetologia 1998;41:79-85.